Skip to main content
. 2021 Nov 3;12:696387. doi: 10.3389/fneur.2021.696387

Figure 2.

Figure 2

Estimated body weight-normalized eculizumab exposure parameters for the total patient population, Asian, non-Asian, Japanese, and non-Japanese patients. Results are shown for parameters at steady state: (A) AUC, (B) Cmax, and (C) Ctrough. Exposures were normalized by body weight using the exponent estimated in the final model. AUC, area under the concentration–time curve within one dosing interval; Cmax, peak concentration; Ctrough, concentration at the end of the dosage interval; ss, steady state.